Announcements and Notices - [Placing / Issue of Shares under a General Mandate]

Zai Lab Limited operates as a biopharmaceutical company. The Company researches and develops therapeutic technology for antibody-based oncology, autoimmune, and infectious diseases treatments. Zai Lab also manufactures drugs in the form of capsules, injections, and liquids. Zai Lab serves patients worldwide.

Voluntary Announcement - Closing Of The Offering Of American Depositary Shares And Full Exercise Of The Option

Next Day Disclosure Return

Announcements and Notices - [Share Scheme]

Grant Of Restricted Share Units

Announcements and Notices - [Overseas Regulatory Announcement - Issue of Securities and Related Matters]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Zai Lab (9688 HK)

Voluntary Announcement - Closing Of The Offering Of American Depositary Shares And Full Exercise Of The Option

Next Day Disclosure Return

Grant Of Restricted Share Units

Next Day Disclosure Return

Overseas Regulatory Announcement - Form 8-K

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)